Results 211 to 220 of about 126,105 (358)

Coated glucose microbeads stimulate enteric hormone release and improve glucose tolerance in Phase 1 and 2 clinical trials

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Incretin agonists are used to treat obesity and metabolic dysfunction. Instead of systemically delivering high levels of hormone receptor agonists that can lead to adverse effects, we tested and optimized oral microbead formulations that activate endogenous enteroendocrine signalling systems via distal nutrient‐sensing cells.
Kai Deusch   +9 more
wiley   +1 more source

Perforation of a Metastatic Bronchogenic Carcinoma to the Jejunum

open access: bronze, 1967
D. Gareth Wootton   +2 more
openalex   +1 more source

ForePass outperforms Semaglutide in weight control, glucose metabolism, and gut microbiota in swine

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aims This study evaluated the metabolic efficacy of ForePass—a novel, incision‐free, reversible, endoscopically delivered device that mimics biliopancreatic diversion—in growing pigs. The primary aim was the superiority of ForePass over Semaglutide in improving insulin sensitivity (SI).
Sara Russo   +16 more
wiley   +1 more source

Management of a diaphragmatic hernia using self‐locking knots

open access: yesEquine Veterinary Education, EarlyView.
Summary A 4‐year‐old Thoroughbred gelding was presented with a history of severe colic signs that were non‐responsive to non‐steroidal anti‐inflammatory drugs. During initial evaluation, distended small intestine was observed, together with continued colic signs and a serosanguinous abdominocentesis sample.
A. Gillen   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy